{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:24:40Z","timestamp":1787772280211,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>CXCL10 (C-X-C motif chemokine ligand 10) is a chemokine induced by interferon-\u03b3 that is crucial in the recruitment of CD8+ (cluster differentiation) T cells to the sites of depigmentation in vitiligo. It has emerged as a potential biomarker for disease activity. However, its correlation with dermoscopic patterns and clinical severity in non-segmental vitiligo remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Objectives:<\/jats:title>\n                    <jats:p>To estimate serum CXCL10 levels in patients with non-segmental vitiligo in comparison to healthy controls and to correlate CXCL10 levels with dermoscopic findings and clinical severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study comprised 80 patients and 40 age- and sex-matched healthy controls. Participants underwent clinical evaluation, dermoscopy (BPLeFoSK scoring), and assessment of disease activity and severity using Vitiligo Disease Activity Score (VIDA) and Vitiligo Area Scoring Index (VASI) scores, respectively. Serum CXCL10 levels were measured using enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean serum CXCL10 level was markedly increased in vitiligo patients (118.7 \u00b1 78.0 pg\/mL) compared to controls (35.6 \u00b1 37.9 pg\/mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Levels were notably higher in active (154.0 \u00b1 77.8 pg\/mL) than stable disease (61.3 \u00b1 23.9 pg\/mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). A strong inverse correlation was found between CXCL10 and the BPLeFoSK score (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u20130.613,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and a positive correlation with the VIDA score (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Dermoscopic features, such as poorly defined borders, absent perifollicular pigmentation, and micro-Koebnerization, were significantly associated with higher CXCL10 levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>This cross-sectional study design precludes the evaluation of causality or treatment response. CXCL10 levels were measured at a single time point, limiting insights into temporal variation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serum CXCL10 is significantly elevated in active non-segmental vitiligo and correlates well with disease activity and VIDA score. It shows promise as a noninvasive biomarker for monitoring disease activity but not for assessing disease extent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_735_25","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:00:38Z","timestamp":1781805638000},"page":"512-519","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Serum CXCL10 Levels in Non-Segmental Vitiligo and Its Correlation with Dermoscopic Findings and Disease Severity: A Cross-Sectional Study"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2003-7671","authenticated-orcid":false,"given":"Ishrat B.","family":"Ismail","sequence":"first","affiliation":[{"name":"Postgraduate Department of Dermatology, Venereology, and Leprosy, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-6832","authenticated-orcid":false,"given":"Yasmeen J.","family":"Bhat","sequence":"additional","affiliation":[{"name":"Postgraduate Department of Dermatology, Venereology, and Leprosy, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-3790","authenticated-orcid":false,"given":"Rafiqa","family":"Eachkoti","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3521-3789","authenticated-orcid":false,"given":"Mohd S. Ul","family":"Islam","sequence":"additional","affiliation":[{"name":"Postgraduate Department of Dermatology, Venereology, and Leprosy, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"R1-20260629","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.15743","article-title":"Vitiligo: A focus on pathogenesis and its therapeutic implications","volume":"48","author":"Bergqvist","year":"2021","journal-title":"J Dermatol"},{"key":"R2-20260629","doi-asserted-by":"crossref","first-page":"e0163806","DOI":"10.1371\/journal.pone.0163806","article-title":"The prevalence of vitiligo: A meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PloS One"},{"key":"R3-20260629","doi-asserted-by":"crossref","first-page":"e2023315S","DOI":"10.5826\/dpc.1304S2a315S","article-title":"Vitiligo: Epidemiology and economic impact","volume":"13","author":"Naldi","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"R4-20260629","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"R5-20260629","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8+T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"R6-20260629","doi-asserted-by":"crossref","first-page":"790125","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: A review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"R7-20260629","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjd.20596","article-title":"British Association of Dermatologists guidelines for the management of people with vitiligo 2021","volume":"186","author":"Eleftheriadou","year":"2022","journal-title":"Br J Dermatol"},{"key":"R8-20260629","doi-asserted-by":"crossref","first-page":"e2023197","DOI":"10.5826\/dpc.1304a197","article-title":"Dermatoscopic patterns in vitiligo","volume":"13","author":"God\u00ednez-Chaparro","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"R9-20260629","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/JCAS.JCAS_75_18","article-title":"Cross-sectional study of dermatoscopic findings in relation to activity in vitiligo: BPLeFoSK criteria for stability","volume":"12","author":"Nirmal","year":"2019","journal-title":"J Cutan Aesthet Surg"},{"key":"R10-20260629","doi-asserted-by":"crossref","first-page":"9","DOI":"10.25259\/IJDVL_793_2023","article-title":"Differential expression of serum CXCL9 and CXCL10 levels in vitiligo patients and their correlation with disease severity and stability: A cross-sectional study","volume":"91","author":"Aulakh","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R11-20260629","first-page":"36","article-title":"Assessment of vitiligo treatment outcome: Review of useful methods","volume":"3","author":"Marrakchi","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"R12-20260629","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","article-title":"Vitiligo: Compendium of clinico-epidemiological features","volume":"73","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-20260629","first-page":"5617838","article-title":"Prevalence and clinical characteristics of itch in vitiligo and its clinical significance","author":"Vachiramon","year":"2017","journal-title":"Biomed Res Int. 2017"},{"key":"R14-20260629","first-page":"27","article-title":"Chemokines in vitiligo pathogenesis: CXCL10 and 12","volume":"14","author":"Gharib","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"R15-20260629","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1346-8138.1999.tb02067.x","article-title":"Vitiligo: Clinical findings in 1436 patients","volume":"26","author":"Handa","year":"1999","journal-title":"J Dermatol"},{"key":"R16-20260629","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4103\/0378-6323.45144","article-title":"Clinical and sociodemographic study of vitiligo","volume":"74","author":"Shah","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R17-20260629","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol Clin"},{"key":"R18-20260629","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21608\/ejmr.2022.216156","article-title":"Study of detection of serum CXCL10 in vitiligo patients","volume":"3","author":"El-Rifaie","year":"2022","journal-title":"Egypt J Med Res"},{"key":"R19-20260629","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"R20-20260629","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1346-8138.14004","article-title":"Role of chemokines and the corresponding receptors in vitiligo: A pilot study","volume":"45","author":"Yang","year":"2018","journal-title":"J Dermatol"},{"key":"R21-20260629","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.12691","article-title":"Inflammasome activation and vitiligo\/non-segmental vitiligo progression","volume":"170","author":"Marie","year":"2014","journal-title":"Br J Dermatol"},{"key":"R22-20260629","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1111\/jocd.14922","article-title":"Differentiating active from stable Vitiligo: The role of dermoscopic findings and their relation to CXCL10","volume":"21","author":"Ibrahim","year":"2022","journal-title":"J Cosmet Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_735_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:36:14Z","timestamp":1787769374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_735_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_735_25","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}